Hs.HRAS G12C Citations (1)
Originally described in: RAS mutant collection V2.0Esposito unpublished
Articles Citing Hs.HRAS G12C
| Articles |
|---|
| Sotorasib is a pan-RASG12C inhibitor capable of driving clinical response in NRASG12C cancers. Rubinson DA, Tanaka N, Fece de la Cruz F, Kapner KS, Rosenthal MH, Norden BL, Barnes H, Ehnstrom S, Morales-Giron AA, Brais LK, Lemke CT, Aguirre AJ, Corcoran RB. Cancer Discov. 2024 Jan 18. doi: 10.1158/2159-8290.CD-23-1138. PubMed |
If you have published an article using this material, please email us at [email protected] to have your article added to this page.